250 related articles for article (PubMed ID: 25399696)
1. Regulation of cell cycle of hepatocellular carcinoma by NF90 through modulation of cyclin E1 mRNA stability.
Jiang W; Huang H; Ding L; Zhu P; Saiyin H; Ji G; Zuo J; Han D; Pan Y; Ding D; Ma X; Zhang Y; Wu J; Yi Q; Liu JO; Huang H; Dang Y; Yu L
Oncogene; 2015 Aug; 34(34):4460-70. PubMed ID: 25399696
[TBL] [Abstract][Full Text] [Related]
2. Expression of a cyclin E1 isoform in mice is correlated with the quiescent cell cycle status of hepatocytes in vivo.
Zschemisch NH; Liedtke C; Dierssen U; Nevzorova YA; Wüstefeld T; Borlak J; Manns MP; Trautwein C
Hepatology; 2006 Jul; 44(1):164-73. PubMed ID: 16799991
[TBL] [Abstract][Full Text] [Related]
3. HuR contributes to cyclin E1 deregulation in MCF-7 breast cancer cells.
Guo X; Hartley RS
Cancer Res; 2006 Aug; 66(16):7948-56. PubMed ID: 16912169
[TBL] [Abstract][Full Text] [Related]
4. Cyclin E1 and cyclin-dependent kinase 2 are critical for initiation, but not for progression of hepatocellular carcinoma.
Sonntag R; Giebeler N; Nevzorova YA; Bangen JM; Fahrenkamp D; Lambertz D; Haas U; Hu W; Gassler N; Cubero FJ; Müller-Newen G; Abdallah AT; Weiskirchen R; Ticconi F; Costa IG; Barbacid M; Trautwein C; Liedtke C
Proc Natl Acad Sci U S A; 2018 Sep; 115(37):9282-9287. PubMed ID: 30150405
[TBL] [Abstract][Full Text] [Related]
5. NF90 stabilizes cyclin E1 mRNA through phosphorylation of NF90-Ser382 by CDK2.
Ding D; Huang H; Li Q; Yu W; Wang C; Ma H; Wu J; Dang Y; Yu L; Jiang W
Cell Death Discov; 2020; 6():3. PubMed ID: 32123579
[TBL] [Abstract][Full Text] [Related]
6. Targeting ODC1 inhibits tumor growth through reduction of lipid metabolism in human hepatocellular carcinoma.
Choi Y; Oh ST; Won MA; Choi KM; Ko MJ; Seo D; Jeon TW; Baik IH; Ye SK; Park KU; Park IC; Jang BC; Seo JY; Lee YH
Biochem Biophys Res Commun; 2016 Sep; 478(4):1674-81. PubMed ID: 27592554
[TBL] [Abstract][Full Text] [Related]
7. NF90 regulates PARP1 mRNA stability in hepatocellular carcinoma.
Song D; Huang H; Wang J; Zhao Y; Hu X; He F; Yu L; Wu J
Biochem Biophys Res Commun; 2017 Jun; 488(1):211-217. PubMed ID: 28487110
[TBL] [Abstract][Full Text] [Related]
8. LncRNA LINC00470 promotes proliferation through association with NF45/NF90 complex in hepatocellular carcinoma.
Huang W; Liu J; Yan J; Huang Z; Zhang X; Mao Y; Huang X
Hum Cell; 2020 Jan; 33(1):131-139. PubMed ID: 31612313
[TBL] [Abstract][Full Text] [Related]
9. Metformin suppresses hepatocellular carcinoma cell growth through induction of cell cycle G1/G0 phase arrest and p21CIP and p27KIP expression and downregulation of cyclin D1 in vitro and in vivo.
Cai X; Hu X; Cai B; Wang Q; Li Y; Tan X; Hu H; Chen X; Huang J; Cheng J; Jing X
Oncol Rep; 2013 Nov; 30(5):2449-57. PubMed ID: 24008375
[TBL] [Abstract][Full Text] [Related]
10. Chromatin remodeling gene ARID2 targets cyclin D1 and cyclin E1 to suppress hepatoma cell progression.
Duan Y; Tian L; Gao Q; Liang L; Zhang W; Yang Y; Zheng Y; Pan E; Li S; Tang N
Oncotarget; 2016 Jul; 7(29):45863-45875. PubMed ID: 27351279
[TBL] [Abstract][Full Text] [Related]
11. Silibinin efficacy against human hepatocellular carcinoma.
Varghese L; Agarwal C; Tyagi A; Singh RP; Agarwal R
Clin Cancer Res; 2005 Dec; 11(23):8441-8. PubMed ID: 16322307
[TBL] [Abstract][Full Text] [Related]
12. Notch1 signaling inhibits growth of human hepatocellular carcinoma through induction of cell cycle arrest and apoptosis.
Qi R; An H; Yu Y; Zhang M; Liu S; Xu H; Guo Z; Cheng T; Cao X
Cancer Res; 2003 Dec; 63(23):8323-9. PubMed ID: 14678992
[TBL] [Abstract][Full Text] [Related]
13. Water extract of Hedyotis Diffusa Willd suppresses proliferation of human HepG2 cells and potentiates the anticancer efficacy of low-dose 5-fluorouracil by inhibiting the CDK2-E2F1 pathway.
Chen XZ; Cao ZY; Chen TS; Zhang YQ; Liu ZZ; Su YT; Liao LM; Du J
Oncol Rep; 2012 Aug; 28(2):742-8. PubMed ID: 22641337
[TBL] [Abstract][Full Text] [Related]
14. In Silico Identification and In Vitro and In Vivo Validation of Anti-Psychotic Drug Fluspirilene as a Potential CDK2 Inhibitor and a Candidate Anti-Cancer Drug.
Shi XN; Li H; Yao H; Liu X; Li L; Leung KS; Kung HF; Lu D; Wong MH; Lin MC
PLoS One; 2015; 10(7):e0132072. PubMed ID: 26147897
[TBL] [Abstract][Full Text] [Related]
15. Swainsonine inhibits growth and potentiates the cytotoxic effect of paclitaxel in hepatocellular carcinoma in vitro and in vivo.
You N; Liu W; Wang T; Ji R; Wang X; Gong Z; Dou K; Tao K
Oncol Rep; 2012 Dec; 28(6):2091-100. PubMed ID: 22993037
[TBL] [Abstract][Full Text] [Related]
16. HOXA7 stimulates human hepatocellular carcinoma proliferation through cyclin E1/CDK2.
Li Y; Yang XH; Fang SJ; Qin CF; Sun RL; Liu ZY; Jiang BY; Wu X; Li G
Oncol Rep; 2015 Feb; 33(2):990-6. PubMed ID: 25501982
[TBL] [Abstract][Full Text] [Related]
17. Total alkaloids of Rubus aleaefolius Poir. inhibit the STAT3 signaling pathway leading to suppression of proliferation and cell cycle arrest in a mouse model of hepatocellular carcinoma.
Zhao J; Lin W; Cao Z; Liu L; Zhuang Q; Zhong X; Hong Z; Peng J
Oncol Rep; 2013 Sep; 30(3):1309-14. PubMed ID: 23828071
[TBL] [Abstract][Full Text] [Related]
18. Suppression of MicroRNA-7 (miR-7) Biogenesis by Nuclear Factor 90-Nuclear Factor 45 Complex (NF90-NF45) Controls Cell Proliferation in Hepatocellular Carcinoma.
Higuchi T; Todaka H; Sugiyama Y; Ono M; Tamaki N; Hatano E; Takezaki Y; Hanazaki K; Miwa T; Lai S; Morisawa K; Tsuda M; Taniguchi T; Sakamoto S
J Biol Chem; 2016 Sep; 291(40):21074-21084. PubMed ID: 27519414
[TBL] [Abstract][Full Text] [Related]
19. miR-451 inhibits cell proliferation in human hepatocellular carcinoma through direct suppression of IKK-β.
Li HP; Zeng XC; Zhang B; Long JT; Zhou B; Tan GS; Zeng WX; Chen W; Yang JY
Carcinogenesis; 2013 Nov; 34(11):2443-51. PubMed ID: 23740840
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-195 inhibits the proliferation of human glioma cells by directly targeting cyclin D1 and cyclin E1.
Hui W; Yuntao L; Lun L; WenSheng L; ChaoFeng L; HaiYong H; Yueyang B
PLoS One; 2013; 8(1):e54932. PubMed ID: 23383003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
